Expressing the sense of Congress that governmental entities should use a portion of the proceeds from litigation against opioid manufacturers and distributors to increase participation in drug take back programs and for the safe disposal of collected, unused medicines.

Civil actions and liability Consumer affairs Drug trafficking and controlled substances Health Prescription drugs Solid waste and recycling State and local finance State and local government operations Transportation costs +6...